Stage one: Applications are evaluated to identify scientifically excellent research that will further the field, is novel and will ensure Canada continues to have international impact within the area of regenerative medicine. The evaluation of the scientific merit of an application is performed by SCN’s international peer review committees, comprising international subject matter experts drawn from academia and industry. The 2025 funding competition was made possible through the expertise and dedicated efforts of a committee of 64 Canadian and international peer reviewers. The peer reviewers who contributed to the 2025 funding competition are listed below.

Stage two: A strategic evaluation of highly ranked peer reviewed applications is conducted by SCN’s Research Management Committee (RMC). The RMC is responsible for considering how each potential project aligns with SCN’s mandate, budget needs, partner support, project potential for clinical and/or commercial translation, HQP training, knowledge mobilization, and the fostering of equity, diversity and inclusion within the multi-disciplinary research team.

Based on the Stage one scientific peer review and the Stage two strategic evaluation, the RMC and SCN Management make project funding recommendations for approval by SCN’s Board of Directors.

SCN uses a Continual Review process for all projects approved by SCN’s Board of Directors to ensure a research project’s milestones and deliverables are being met and that SCN funds are appropriately invested. Continual Review is conducted by the RMC, which offers insight and direction in reviewing the annual project progress reports. The RMC may also directly meet with investigators to better understand the nuances of their research so investigators receive the best possible feedback and support.